A PROVEN PLATFORM.
Numerous clinical studies demonstrate what these leading centers already know: that the CyberKnife’s precise treatment delivery safely allows to expand radiosurgery indications.
Page 1 of 10
We caught up on all the news about the Phase 3 Randomized PACE Trial on SBRT in Patients with Localized Prostate Cancer, with Dr. Nicholas van As, Medical Director and Consultant Clinical Oncologist of The Royal Marsden NHS Foundation Trust and Lead investigator of the PACE trial.
Watch this patient testimonial on the CyberKnife System treatment for Prostate Cancer
Watch how the CyberKnife System treats prostate cancer in this animation.
Watch how the CyberKnife System treats lung cancer in this animation.
Watch how the CyberKnife System treats brain tumors in this animation.
Read about two large prospective, multi-institutional and CyberKnife® System only clinical studies report excellent clinical outcomes at
five years post-treatment.
Listen to Dr. Donald B. Fuller who was an early adopter of the CyberKnife System
Explore a data security and privacy white paper showing how Accuray’s multi-modal approach addresses cybersecurity and data privacy.
Read about the proven safety and efficacy of the CyberKnife System for the treatment of trigeminal neuralgia.
Results of a 21-Center Study on the use of the CyberKnife System to treat prostate cancer with SBRT.